Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 9Neoplasms 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Multiple Myeloma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sarcoma 2Rectal Neoplasms 2Radiation Injuries 2Prostatic Neoplasms 2Preleukemia 2Precancerous Conditions 2Osteosarcoma 2Neoplasms by Histologic Type 2Nasopharyngeal Carcinoma 2Myelodysplastic Syndromes 2Multiple Chronic Conditions 2Melanoma 2Lymphoproliferative Disorders 2Lymphatic Diseases 2Lung Neoplasms 2Leukemia, Myeloid 2Leukemia, Lymphoid 2Leukemia, Biphenotypic, Acute 2

Interventions

Carboplatin 7Trastuzumab 6Docetaxel 5pembrolizumab 4Paclitaxel 4Oxaliplatin 4Fluorouracil 4Cytarabine 4Cyclophosphamide 4Azacitidine 4pertuzumab 3Radiotherapy 3Observation 3Neoadjuvant Therapy 3Epirubicin 3Endoscopy 3Cisplatin 3Chemoradiotherapy 3Capecitabine 3venetoclax 2toripalimab 2sargramostim 2olaparib 2durvalumab 2cc-486 2Tretinoin 2Surgical Procedures, Operative 2Standard of Care 2Pemetrexed 2Monatide (IMS 3015) 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Patient Reported Outcome Measures × Clear all
NCT05926024 2026-03-11

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

UNC Lineberger Comprehensive Cancer Center

Active not recruiting
253 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡